|
CCDC15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.101000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.563800E-01 |
| Normal-vs-Stage2 |
8.556600E-01 |
| Normal-vs-Stage3 |
6.658800E-01 |
| Normal-vs-Stage4 |
3.783000E-01 |
| Stage1-vs-Stage2 |
8.901400E-01 |
| Stage1-vs-Stage3 |
4.103600E-01 |
| Stage1-vs-Stage4 |
3.318600E-01 |
| Stage2-vs-Stage3 |
6.420000E-01 |
| Stage2-vs-Stage4 |
4.099800E-01 |
| Stage3-vs-Stage4 |
2.477800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.181400E-01 |
| Normal-vs-AfricanAmerican |
2.064800E-01 |
| Normal-vs-Asian |
7.366800E-01 |
| Caucasian-vs-AfricanAmerican |
7.863800E-02 |
| Caucasian-vs-Asian |
9.627200E-01 |
| AfricanAmerican-vs-Asian |
4.642600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.944000E-01 |
| Normal-vs-Female |
5.641800E-02 |
| Male-vs-Female |
1.138390E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.791580E-01 |
| Normal-vs-Extreme_Weight |
2.692000E-01 |
| Normal-vs-Obese |
3.111800E-01 |
| Normal-vs-Extreme_Obese |
8.600800E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.782400E-01 |
| Normal_Weight-vs-Obese |
5.493900E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.955800E-01 |
| Extreme_Weight-vs-Obese |
7.833600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.940370E-01 |
| Obese-vs-Extreme_Obese |
6.524000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.375000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.974800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.138200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.312130E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.652800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.594350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.991900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.193900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.733800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.642160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.548600E-01 |
| Normal-VS-Type2 PRCC |
5.645500E-02 |
| Normal-VS-KIRP CIMP |
3.276400E-01 |
| Normal-VS-Unclassified PRCC |
2.154400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.892300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.141800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.754630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.904820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.687900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.765000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.792800E-01 |
| Normal-vs-N1 |
4.292800E-01 |
| Normal-vs-N2 |
1.154370E-02 |
| N0-vs-N1 |
2.599400E-01 |
| N0-vs-N2 |
2.611800E-01 |
| N1-vs-N2 |
2.058000E-02 |
|
|
